Ati Nr 293 Pharm Final Review Exam 2022

ATI NR 293 PHARM FINAL REVIEW EXAM 2022. This is an all-inclusive guide to ATI NR 293 PHARM FINAL REVIEW EXAM 2022. A nurse is preparing a client for surgery. Prior to administering the prescribed hydroxyzine, the nurse should explain to the client that the medication is for which of the following indications? (Select all that apply.) a) Controlling emesis b) Diminishing anxiety c) Reducing the amount of narcotics needed for pain relief d) Preventing thrombus formation e) Drying secretions  A nurse is caring for a client who has acute respiratory distress syndrome (ARDS), and requires mechanical ventilation. The client receives a prescription for pancuronium. The nurse recognizes that this medication is for which of the following purposes? a) Decrease chest wall compliance b) Suppress respiratory effort i) Rationale: Neuromuscular blocking agents, such as pancuronium, induce paralysis and suppress the client's respiratory efforts to the point of apnea, allowing the mechanical ventilator to take over the work of breathing for the client. This therapy is especially helpful for a client who has ARDS and poor lung compliance. c) Induce sedation d) Decrease respiratory secretions  A nurse is caring for a client who is taking lisinopril. Which of the following outcomes indicates a therapeutic effect of the medication? a) Decreased blood pressure i) Rationale: Lisinopril, an ACE inhibitor, may be used alone or in combination with other antihypertensives in the management of hypertension and congestive heart failure. A therapeutic effect of the medication is a decrease in blood pressure. b) Increase of HDL cholesterol i) Rationale: This is not an intended effect of lisinopril. c) Prevention of bipolar manic episodes i) Rationale: This is not an intended effect of lisinopril. d) Improved sexual function i) Rationale: This is not an intended effect of lisinopril. Lisinopril may in fact cause sexual dysfunction and impotence.  A nurse is caring for a client who has poison ivy and is prescribed diphenhydramine. Which of the following instructions should the nurse give regarding the adverse effect of dry mouth associated with diphenhydramine? a) Administer the medication with food b) Chew on sugarless gum or suck on hard, sour candies i) Rationale: Clients who report dry mouth can get the most effective relief by sucking on hard candies (especially the sour varieties that stimulate salivation), chewing gum, or rinsing the mouth frequently. It is the local effect of these actions that provides comfort to the client. c) Place a humidifier at your bedside every evening d) Discontinue the medication and notify your provider  A nurse on an oncology unit is preparing to administer doxorubicin to a client who has breast cancer. Prior to beginning the infusion, the nurse verifies the client's current cumulative lifetime dose of the medication. For which of the following reasons is this verification necessary? a) An excess amount of doxorubicin can lead to myelosuppression. b) Exceeding the lifetime cumulative dose limit of doxorubicin might cause extravasation. c) An excess amount of doxorubicin can lead to cardiomyopathy. i) Rationale: Doxorubicin is an antineoplastic antibiotic used in the treatment of various cancers. Irreversible cardiomyopathy with congestive heart failure can result from repeated doses of doxorubicin, and prolonged use can also cause severe heart damage, even years after the client has stopped taking it. The maximum cumulative dose a client should receive is 550 mg/m or 450 mg/m with a history of radiation to the mediastinum. d) Exceeding the lifetime cumulative dose limit of doxorubicin might produce red tinged urine and sweat.  A nurse on an oncology unit is preparing to administer doxorubicin to a client who has breast cancer. Prior to beginning the infusion, the nurse verifies the client's current cumulative lifetime dose of the medication. For which of the following reasons is this verification necessary? a) An excess amount of doxorubicin can lead to myelosuppression. b) Exceeding the lifetime cumulative dose limit of doxorubicin might cause extravasation.